Myriam Meineck
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Targeting IFN signaling as therapeutic option for lupus nephritis.
Journal: Autoimmunity
Published: August 26, 2026
Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover Trial.
Journal: The Lancet regional health. Europe
Published: December 19, 2025
Anifrolumab in systemic lupus erythematosus: real-world experience from a single academic tertiary care centre.
Journal: Clinical and experimental rheumatology
Published: March 15, 2025
Sex-specific differences in SLE - Significance in the experimental setting of inflammation and kidney damage in MRL-Faslpr mice.
Journal: Autoimmunity
Published: July 15, 2024
A20 in Kidney Transplantation and Autoimmunity.
Journal: International journal of molecular sciences
Published: May 10, 2024
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: March 19, 2024
Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus.
Journal: Journal of neuroinflammation
Published: February 12, 2024
Ptprz Signaling, Tubule-Mediated and Macrophage-Mediated Kidney Injury, and Subsequent CKD.
Journal: Journal of the American Society of Nephrology : JASN
Published: December 15, 2023
Last Updated: 09/26/2026